Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]
Net revenues	$ 487,505	$ 415,591
Cost of services sold	273,068	221,573
Gross profit	214,437	194,018
Selling, general and administrative expenses	(189,020)	(159,877)
Goodwill and other long-lived asset impairment	0	(224,320)	[1]
Interest income	633	785
Interest expense and other	(25,131)	(23,078)
Income (loss) before income taxes	919	(212,472)
Income tax (expense) benefit	(421)	5,416
Net income (loss)	498	(207,056)
Less: Net income attributable to noncontrolling interests	(184)	(121)
Net income (loss) attributable to Gentiva shareholders	314	(207,177)
Comprehensive income (loss)	$ 498	$ (207,056)
Net income (loss) attributable to Gentiva shareholders
Basic	$ 0.01	$ (6.73)
Diluted	$ 0.01	$ (6.73)
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic Weighted average shares outstanding	36,189	30,785
Diluted weighted average common shares outstanding	36,677	30,785

[1] (2)At March 31, 2013, the Company performed an interim impairment test of its Hospice reporting unit. Based on the results of the interim impairment test, the Company recorded a non-cash impairment charge relating to goodwill of approximately $220.8 million As part of that analysis, the Company reviewed the valuation of its owned real estate utilized in the Hospice business. The analysis indicated that two of the Company's hospice inpatient units had estimated fair values lower than their carrying values and, as such, the Company recorded a non-cash impairment charge of approximately $1.9 million. See Note 9.In addition, the Company conducted an evaluation of the various systems used to support its field operations. In connection with that review, the Company made a strategic decision to replace its business intelligence software platform and, as such, recorded a non-cash impairment charge, related to developed software, of approximately $1.6 million.Hospice and corporate assets were reduced by $220.8 million and $3.5 million , respectively, as a result of the impairment.